| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | $51.2M+23.2% | $41.6M+12.5% | $37.0M+22.5% | $30.2M-31.3% | $43.9M-49.4% | $86.8M |
| Accounts receivable, net | $128.3M+0.7% | $127.4M+3.7% | $122.8M-9.9% | $136.3M+9.1% | $125.0M+41.5% | $88.3M |
| Inventory | $82.2M-11.1% | $92.5M+1.3% | $91.3M+7.7% | $84.8M+37.4% | $61.7M+111.8% | $29.1M |
| Prepaid and other current assets | $11.1M-21.9% | $14.2M-16.3% | $16.9M-8.8% | $18.6M-31.9% | $27.2M+260.7% | $7.6M |
| Total current assets | $272.8M-1.0% | $275.6M+2.8% | $268.0M-1.7% | $272.6M+3.6% | $263.1M+24.2% | $211.8M |
| Property and equipment, net | $21.9M-18.9% | $27.0M-26.2% | $36.6M+33.3% | $27.5M+19.5% | $23.0M+234.1% | $6.9M |
| Goodwill | $7.5M+0.0% | $7.5M+0.0% | $7.5M+0.0% | $7.5M-94.9% | $147.6M+196.4% | $49.8M |
| Intangible assets, net | $368.4M-9.0% | $404.7M-16.1% | $482.4M-24.6% | $639.9M-8.0% | $695.2M+262.7% | $191.7M |
| Operating lease assets | $5.1M-21.3% | $6.5M-51.3% | $13.4M-20.0% | $16.7M-2.9% | $17.2M+14.9% | $15.0M |
| Deferred tax assets | $5.5M+16.4% | $4.7M | $0 | — | $481K | $0 |
| Investment and other assets | $2.3M+21.2% | $1.9M-39.8% | $3.1M+19.8% | $2.6M-91.1% | $29.3M+51.1% | $19.4M |
| Total assets | $683.6M-6.1% | $728.0M-10.2% | $810.9M-40.9% | $1.37B+12.0% | $1.23B+147.9% | $494.5M |
| Accounts payable | $10.9M-53.9% | $23.7M+2.8% | $23.0M-37.2% | $36.7M+116.9% | $16.9M+282.5% | $4.4M |
| Accrued liabilities | $130.2M-4.1% | $135.9M+13.4% | $119.8M+7.4% | $111.6M-15.1% | $131.5M+49.1% | $88.2M |
| Current portion of long-term debt | $15.0M-45.1% | $27.3M-1.8% | $27.8M-15.8% | $33.1M+83.3% | $18.0M+20.3% | $15.0M |
| Current portion of contingent consideration | $0-100.0% | $19.6M | $0 | — | — | — |
| Other current liabilities | $4.2M+7.5% | $3.9M-18.7% | $4.8M+33.5% | $3.6M+1.4% | $3.6M-9.4% | $3.9M |
| Total current liabilities | $160.4M-23.8% | $210.4M+19.9% | $175.5M-42.3% | $304.0M+68.1% | $180.9M+47.5% | $122.6M |
| Long-term debt, less current portion | $279.0M-9.5% | $308.3M-16.0% | $367.0M-4.7% | $385.0M+13.4% | $339.6M+95.9% | $173.4M |
| Deferred income tax liabilities | $433K-23.2% | $564K-53.5% | $1.2M-46.0% | $2.2M-98.3% | $133.5M+3871.4% | $3.4M |
| Other long-term liabilities | $15.3M-33.6% | $23.1M-17.3% | $27.9M+22.5% | $22.8M+5.0% | $21.7M-0.0% | $21.7M |
| Total liabilities | $455.1M-16.1% | $542.4M-8.0% | $589.8M-38.6% | $960.4M+38.8% | $692.1M+97.6% | $350.3M |
| Additional paid-in capital | $520.9M+2.5% | $508.1M+2.8% | $494.3M+0.7% | $490.6M+5.4% | $465.3M | — |
| Accumulated deficit | -$334.9M+6.4% | -$357.7M-11.2% | -$321.5M-94.5% | -$165.3M-2403.9% | -$6.6M | — |
| Accumulated other comprehensive loss | -$1.9M+26.2% | -$2.6M-424.1% | $794K+821.8% | -$110K-161.5% | $179K | — |
| Total stockholders’ equity attributable to Bioventus Inc. | $184.1M+24.4% | $147.9M-14.8% | $173.6M-46.6% | $325.2M-29.1% | $458.9M | — |
| Noncontrolling interest | $44.3M+17.7% | $37.7M-20.8% | $47.5M-45.4% | $87.0M+16.2% | $74.9M | — |
| Total stockholders’ equity | $228.4M+23.1% | $185.6M-16.1% | $221.1M-46.4% | $412.2M-22.8% | $533.8M | — |
| Total liabilities and stockholders’ equity | $683.6M-6.1% | $728.0M-10.2% | $810.9M-40.9% | $1.37B+12.0% | $1.23B+147.9% | $494.5M |
| Common Class A | ||||||
| Common stock, value | $16K+0.0% | $16K+0.0% | $16K+0.0% | $16K+0.0% | $16K | — |
| Common Class B | ||||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.